Most recently, it has been identified that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in identical areas as classical opioid receptors, it binds to a big range of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger https://patrickd319ybc0.wikicorrespondence.com/user